Blinatumomab Intravenous and Sandostatin LAR Depot
Determining the interaction of Blinatumomab Intravenous and Sandostatin LAR Depot and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Blinatumomab Intravenous-Sandostatin LAR Depot injection
- Blinatumomab Intravenous-Sani-Supp
- Blinatumomab Intravenous-Sani-Supp rectal
- Blinatumomab Intravenous-Sansert
- Blinatumomab Intravenous-Santyl
- Blinatumomab Intravenous-Saphris
- Sandostatin LAR Depot-Blincyto
- Sandostatin LAR Depot-Blisovi 24 Fe
- Sandostatin LAR Depot-Blisovi 24 FE birth control
- Sandostatin LAR Depot-Blisovi Fe 1.5/30
- Sandostatin LAR Depot-Blisovi Fe 1/20
- Sandostatin LAR Depot-Blocadren